Abstract
My article is in two parts, the first of which seeks to contextualise the subject in the framework of the major realignment of health policies in 2004. The second part deals with the integration of TCM in therapies and research on HIV. This process, in its conceptual and operational modes, is concrete evidence of the "biomedicalisation" of TCM that accelerated in the 1990s. Based on analysis of a number of publications and observations, I will give examples of clinical trials aimed at the scientific certification of AIDS treatments in the wider context of R&D in TCM.